What Has The Market Misjudged About Ameresco After Its 32% Fall?

Ameresco has had a busy stretch, from closing a US$1.8b biofuels joint venture with HASI to reporting mixed quarterly results that highlighted rising revenue but softer net margin. For Ameresco shareholders, the loss from the start of the year was 31.5%, including dividends. If you had put money in at the very beginning of 2026, how should this mix of big contracts, new nuclear projects, and thinner profitability shape expectations over the next few years?

The useful thing about a Narrative is that the reasoning is checkable: the assumptions sit beside the argument, and together they imply an estimated Fair Value you can disagree with.

Ameresco has already moved. Pinpoint other ways to investigate the theme among 39 power grid technology and infrastructure stocks.

The Two Ameresco Stories Investors Had To Weigh

The shares cost US$29.29 at the start of the period, and anyone looking at Ameresco then had to pick between two very different stories.

The bullish narrative put fair value at US$34.22, assuming revenue growth of 9.1% and profit margins reaching 3.6%, supported by government clean energy incentives and an expanding backlog across the United States, Canada, and Europe.

The bearish view argued for fair value of US$11, focusing on higher interest costs, supply chain stress around transformers and batteries, and policy risk that could affect margins and earnings stability.

What The Ameresco Results Actually Tested

The Neogenyx Fuels joint venture gave Ameresco fresh liquidity and a clearer biofuels structure, which supported parts of the bullish story about project depth and funding flexibility. Q2 2026 results told a different story. Revenue moved to US$515.5m from US$472.3m, while net income slipped to US$9.7m and net margin fell from 2.7% to 1.9%. The evidence cut both ways.

The key assumption was that bigger contracts would translate into higher profitability. When you assess another contractor-heavy business, track whether rising backlog and sales are matched by a rising net margin, not just headline growth.

What Ameresco’s Drop May Already Be Pricing In

Ameresco shares are now US$21, after a loss of 31.5% from the start of the year. The selected Narrative still places its Fair Value above that price, anchored in views about backlog quality, recurring revenue from energy assets, and accounting driven earnings noise.

The fall only looks like an opening if you think Ameresco can turn Neogenyx backed assets and higher margin projects into steadier cash flow despite financing and policy risks. That is the concrete bet a buyer at today’s price needs to test.

"Analyst consensus sees Ameresco's project backlog as a revenue visibility tool, but they likely underappreciate the accelerating pace of backlog conversion to contracted status and the improving mix towards higher-margin international and infrastructure projects, supporting not just future revenue, but sustained gross margin expansion and robust earnings growth."

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all

Which Company Could Surprise You Next?

The next headline does not have to be where your research begins. Go straight to the companies and see whether a contrarian opportunity could be taking shape.

• Company 1 - 36% below our estimate - converts a record backlog of data center and modular projects into recurring work.
• Company 2 - 47% below our estimate - absorbs a large merger while trying to preserve relationship banking culture and credit standards.
• Company 3 - 44% below our estimate - tackles a large public infrastructure backlog as labor shortages and technology reshape project economics.

Those are three of them. See every one of the 28 undervalued companies on it →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com